Truist Financial’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-38,414
| Closed | -$6.8M | – | 2634 |
|
|
2020
Q1 | $6.8M | Sell |
38,414
-7,917
| -17% | -$1.49M | 0.02% | 589 |
|
|
2019
Q4 | $8.86M | Buy |
46,331
+42,152
| +1,009% | +$7.6M | 0.02% | 609 |
|
|
2019
Q3 | $703K | Buy |
4,179
+761
| +22% | +$124K | 0.01% | 508 |
|
|
2019
Q2 | $572K | Buy |
3,418
+787
| +30% | +$109K | 0.01% | 554 |
|
|
2019
Q1 | $385K | Buy |
2,631
+200
| +8% | +$29K | 0.01% | 623 |
|
|
2018
Q4 | $325K | Sell |
2,431
-339
| -12% | -$55.6K | 0.01% | 628 |
|
|
2018
Q3 | $528K | Buy |
2,770
+117
| +4% | +$21.5K | 0.01% | 574 |
|
|
2018
Q2 | $442K | Sell |
2,653
-595
| -18% | -$95.5K | 0.01% | 598 |
|
|
2018
Q1 | $547K | Sell |
3,248
-316
| -9% | -$53K | 0.01% | 562 |
|
|
2017
Q4 | $583K | Sell |
3,564
-2,851
| -44% | -$512K | 0.01% | 557 |
|
|
2017
Q3 | $1.31M | Sell |
6,415
-1,252
| -16% | -$291K | 0.03% | 427 |
|
|
2017
Q2 | $1.86M | Sell |
7,667
-1,922
| -20% | -$452K | 0.04% | 369 |
|
|
2017
Q1 | $2.29M | Sell |
9,589
-1,899
| -17% | -$442K | 0.05% | 342 |
|
|
2016
Q4 | $2.41M | Sell |
11,488
-1,646
| -13% | -$341K | 0.05% | 339 |
|
|
2016
Q3 | $3.02M | Sell |
13,134
-414
| -3% | -$101K | 0.06% | 315 |
|
|
2016
Q2 | $3.13M | Buy |
13,548
+861
| +7% | +$199K | 0.07% | 305 |
|
|
2016
Q1 | $3.4M | Sell |
12,687
-1,286
| -9% | -$368K | 0.09% | 246 |
|
|
2015
Q4 | $4.37M | Sell |
13,973
-32
| -0.2% | -$9.53K | 0.11% | 206 |
|
|
2015
Q3 | $3.81M | Buy |
+14,005
| New | +$4.3M | 0.1% | 234 |
|
|
2015
Q2 | – | Sell |
-12,754
| Closed | -$3.8M | – | 864 |
|
|
2015
Q1 | $3.8M | Buy |
12,754
+4,402
| +53% | +$1.26M | 0.11% | 212 |
|
|
2014
Q4 | $2.15M | Buy |
8,352
+2,461
| +42% | +$615K | 0.06% | 272 |
|
|
2014
Q3 | $1.42M | Buy |
5,891
+1,829
| +45% | +$409K | 0.04% | 320 |
|
|
2014
Q2 | $906K | Buy |
4,062
+101
| +3% | +$20.9K | 0.03% | 398 |
|
|
2014
Q1 | $815K | Buy |
3,961
+938
| +31% | +$186K | 0.03% | 404 |
|
|
2013
Q4 | $508K | Buy |
3,023
+1,038
| +52% | +$162K | 0.02% | 506 |
|
|
2013
Q3 | $285K | Buy |
+1,985
| New | +$264K | 0.01% | 623 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Truist Financial's AGN Position: Q2 2020 in Review
Truist Financial sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 38,414 shares — an estimated $6.8M sold.
Truist Financial first reported a position in AGN in Q3 2013 and held it in 26 quarters. The position peaked at $8.86M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Truist Financial reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Truist Financial sold 38,414 Allergan plc shares in Q2 2020, an estimated $6.8M.
- Truist Financial first reported a position in Allergan plc in Q3 2013 and held it in 26 quarters.
- Truist Financial's Allergan plc position peaked at $8.86M in Q4 2019.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Truist Financial's 13F filing for Q2 2020, filed 14 Aug 2020.